PCV60 - Estimating the Cost Per Percent Point Reduction in Ldl-C for Patients Treated with Pcsk9 Inhibitors in a Large National Health Plan

Autor: Gitlin, M, Patel, J, Burton, T, Seare, J, Whang, J, Harrison, DJ
Zdroj: In Value in Health May 2016 19(3):A50-A50
Databáze: ScienceDirect
Externí odkaz: